Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer’s DiseaseRobert Martone, J. Steven Jacobsen, Anthony F. Kreft et al.|Journal of Pharmacology and Experimental Therapeutics|2009Cited by 157
Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer’s DiseaseScott C. Mayer, J. Steven Jacobsen, Anthony F. Kreft et al.|Journal of Medicinal Chemistry|2008Cited by 111
O3‐06‐07: GSI‐953 is a potent APP‐selective gamma‐secretase inhibitor for the treatment of Alzheimer's diseaseSteven J. Jacobsen, Robert Martone, Thomas A. Comery et al.|Alzheimer s & Dementia|2009Cited by 12
CCDC 767715: Experimental Crystal Structure DeterminationScott C. Mayer, J. Steven Jacobsen, Anthony F. Kreft et al.|The Cambridge Structural Database|2010Cited by 0